促销时间表 Allakos Inc.
先进的时间表
简单图表
关于公司 Allakos Inc.
Allakos Inc. работает как биофармацевтическая компания клинической стадии. Компания разрабатывает антолимаб (AK002) для лечения эозинофильного гастрита и эозинофильного гастроэнтерита, хронической крапивницы, вялого системного мастоцитоза и тяжелого аллергического конъюнктивита. Allakos Inc. была основана в 2012 году со штаб-квартирой в Редвуд-Сити, штат Калифорния.IPO date | 2018-07-19 |
---|---|
ISIN | US01671P1003 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Див.доход ао | 0 |
Сайт | http://www.allakos.com |
Цена ао | 0.9688 |
每日价格变化: | +17.48% (1.03) |
---|---|
每周价格变化: | +41.44% (0.8555) |
每月价格变化: | -4.72% (1.27) |
3个月内价格变化: | -7.63% (1.31) |
六个月内的价格变化: | +31.07% (0.9232) |
每年价格变化: | -6.92% (1.3) |
3年内价格变化: | -78.32% (5.58) |
5年内价格变化: | -97.97% (59.54) |
10年价格变化: | 0% (1.21) |
年初以来价格变化: | -4.72% (1.27) |
|
低估
|
效率
|
|||||||||||||||||||||||||||||||||||||
股息
|
责任
|
成长冲动
|
交易日期 | 披露日期 | 内幕 | 类型 | 价格 | 体积 | 数量 | 分享最多, % | 之后分享, % | 文档 |
---|---|---|---|---|---|---|---|---|---|
05.12.2024 | 05.12.2024 | Alexander Robert Officer |
购买 | 1.1 | 35 713 | 32466 | 0 | 0.06 | 关联 |
06.09.2024 | 06.09.2024 | Tomasi Adam Officer |
购买 | 0.64 | 14 055 | 21961 | 0 | 0.04 | 关联 |
06.09.2024 | 06.09.2024 | Radford Harlan Baird Officer |
购买 | 0.64 | 8 746 | 13665 | 0 | 0.03 | 关联 |
07.06.2021 | 07.06.2021 | Tomasi Adam President and COO |
销售 | 92.03 | 228 879 | 2487 | 0 | -0.01 | 关联 |
04.06.2021 | 07.06.2021 | Tomasi Adam President and COO |
销售 | 90.26 | 57 947 | 642 | 0 | 0 | 关联 |
04.06.2021 | 04.06.2021 | Alexander Robert Chief Executive Officer |
销售 | 89.64 | 491 406 | 5482 | 0 | -0.01 | 关联 |
04.06.2021 | 04.06.2021 | Alexander Robert Chief Executive Officer |
销售 | 89.64 | 1 623 650 | 18113 | 0 | -0.04 | 关联 |
04.06.2021 | 04.06.2021 | Alexander Robert Chief Executive Officer |
购买 | 0.69 | 10 016 | 14516 | 0 | 0.03 | 关联 |
03.06.2021 | 04.06.2021 | Alexander Robert Chief Executive Officer |
销售 | 92.09 | 505 022 | 5484 | 0 | -0.01 | 关联 |
03.06.2021 | 04.06.2021 | Alexander Robert Chief Executive Officer |
销售 | 92.14 | 1 337 600 | 14517 | 0 | -0.03 | 关联 |
03.06.2021 | 04.06.2021 | Alexander Robert Chief Executive Officer |
购买 | 0.69 | 10 017 | 14517 | 0 | 0.03 | 关联 |
02.06.2021 | 04.06.2021 | Alexander Robert Chief Executive Officer |
销售 | 94.56 | 518 567 | 5484 | 0 | -0.01 | 关联 |
02.06.2021 | 04.06.2021 | Alexander Robert Chief Executive Officer |
销售 | 94.55 | 1 372 580 | 14517 | 0 | -0.03 | 关联 |
02.06.2021 | 04.06.2021 | Alexander Robert Chief Executive Officer |
购买 | 0.69 | 10 017 | 14517 | 0 | 0.03 | 关联 |
29.12.2020 | 31.12.2020 | Alexander Robert Chief Executive Officer |
购买 | 4.31 | 35 514 | 8240 | 0 | 0.02 | 关联 |
29.12.2020 | 31.12.2020 | Tomasi Adam President, COO and CFO |
购买 | 4.31 | 23 343 | 5416 | 0 | 0.01 | 关联 |
机构 | 体积 | 分享, % |
---|---|---|
BVF Inc. | 8552417 | 9.73 |
Price (T.Rowe) Associates Inc | 7920708 | 9.01 |
NEA Management Company, LLC | 6147260 | 7 |
Blackrock Inc. | 5116088 | 5.82 |
RiverVest Venture Management LLC | 4987522 | 5.68 |
Blackstone Inc | 4096652 | 4.66 |
Redmile Group, LLC | 3670447 | 4.18 |
Vanguard Group Inc | 3255642 | 3.7 |
Citadel Advisors Llc | 3244922 | 3.69 |
Morgan Stanley | 3025269 | 3.44 |
ETF | 分享, % | 本年盈利能力, % | 股息, % |
---|---|---|---|
ProShares UltraShort Nasdaq Biotechnology | 0.49 | -40.36 | 1.76 |
PGIM QMA Strategic Alpha Small-Cap Growth ETF | 0.25 | 47.14 | 11.40 |
iShares Micro-Cap ETF | 0.01086 | 17.09 | 1.54048 |
导师 | 职称 | 支付 | 出生年份 |
---|---|---|---|
Mr. Baird Radford III | Chief Financial Officer | 708.26k | 1970 (55 年) |
Dr. Robert Alexander Ph.D. | CEO & Director | 1.46M | 1970 (55 年) |
Dr. Adam L. Tomasi Ph.D. | President | 1.11M | 1970 (55 年) |
Mr. Alan Chang | Director of Medical Affairs & Data Analytics | N/A | |
Ms. Mary Cromwell Ph.D. | Chief Technical Officer | N/A | |
Dr. Chin Lee M.D., M.P.H. | Chief Medical Officer | N/A | 1970 (55 年) |
地址: United States, Redwood City, CA , 975 Island Drive - 在 Google 地图中打开, 打开 Yandex 地图
网站: http://www.allakos.com
网站: http://www.allakos.com